IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
Other Operating Expenses
IDT Australia Ltd
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDT Australia Ltd
ASX:IDT
|
Other Operating Expenses
-AU$1.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-6%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Other Operating Expenses
AU$6.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Other Operating Expenses
-AU$2m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-42%
|
|
Probiotec Ltd
ASX:PBP
|
Other Operating Expenses
-AU$6.3m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Other Operating Expenses
AU$9.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's Other Operating Expenses?
Other Operating Expenses
-1.7m
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Other Operating Expenses amounts to -1.7m AUD.
What is IDT Australia Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
-6%
Over the last year, the Other Operating Expenses growth was 14%. The average annual Other Operating Expenses growth rates for IDT Australia Ltd have been 7% over the past three years , 19% over the past five years , and -6% over the past ten years .